Inari Medical announced that it had filed a patent infringement lawsuit against Imperative Care and Truvic Medical. The suit was filed in the United States District Court for the Northern District of California. Inari is seeking injunctive relief and damages for infringement. Inari believes Truvic is infringing eight of Inari Medical’s patents for the use of aspiration-based thrombectomy devices to treat pulmonary emboli and deep vein thrombosis. Truvic products named in the suit include the Symphony Thrombectomy System. “Inari was founded to improve patients’ lives using purpose-built innovation. Our mission depends on these innovations, and we are deeply committed to protecting our intellectual property rights,” said Drew Hykes, CEO of Inari Medical.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NARI:
- Inari Medical Files Patent Infringement Lawsuit Against Imperative Care and Truvic Medical
- Inari Medical management to meet with BTIG
- Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
- Inari Medical price target lowered to $50 from $55 at Piper Sandler
- Inari Medical price target lowered to $55 from $75 at Canaccord